Titre : Technologie des fibres optiques

Technologie des fibres optiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Technologie des fibres optiques : Questions médicales les plus fréquentes", "headline": "Technologie des fibres optiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Technologie des fibres optiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-04", "dateModified": "2025-03-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Technologie des fibres optiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Physique", "url": "https://questionsmedicales.fr/mesh/D010825", "about": { "@type": "MedicalCondition", "name": "Physique", "code": { "@type": "MedicalCode", "code": "D010825", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "H01.671" } } }, "about": { "@type": "MedicalCondition", "name": "Technologie des fibres optiques", "alternateName": "Fiber Optic Technology", "code": { "@type": "MedicalCode", "code": "D005336", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Joost A van Herwaarden", "url": "https://questionsmedicales.fr/author/Joost%20A%20van%20Herwaarden", "affiliation": { "@type": "Organization", "name": "Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands." } }, { "@type": "Person", "name": "Tilo Kölbel", "url": "https://questionsmedicales.fr/author/Tilo%20K%C3%B6lbel", "affiliation": { "@type": "Organization", "name": "German Aortic Center Hamburg, Department of Vascular Medicine, University hospital Eppendorf UKE, Hamburg, Germany." } }, { "@type": "Person", "name": "Constantijn E V B Hazenberg", "url": "https://questionsmedicales.fr/author/Constantijn%20E%20V%20B%20Hazenberg", "affiliation": { "@type": "Organization", "name": "Department of Vascular Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands." } }, { "@type": "Person", "name": "Wei Peng", "url": "https://questionsmedicales.fr/author/Wei%20Peng", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Giuseppe Panuccio", "url": "https://questionsmedicales.fr/author/Giuseppe%20Panuccio", "affiliation": { "@type": "Organization", "name": "German Aortic Center Hamburg, Department of Vascular Medicine, University hospital Eppendorf UKE, Hamburg, Germany. Electronic address: giuseppe.panuccio@gmail.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A case-control study on immunologic markers of patients with vitiligo.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.113785" } }, { "@type": "ScholarlyArticle", "name": "Case-Control Study of Long COVID, Sapporo, Japan.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37044126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3201/eid2905.221349" } }, { "@type": "ScholarlyArticle", "name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37016998", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001192" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35875004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.913897" } }, { "@type": "ScholarlyArticle", "name": "Significance of temperature in antimuscarinic toxicity: a case-control study.", "datePublished": "2022-06-23", "url": "https://questionsmedicales.fr/article/35735006", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/15563650.2022.2088378" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Disciplines des sciences naturelles", "item": "https://questionsmedicales.fr/mesh/D010811" }, { "@type": "ListItem", "position": 3, "name": "Physique", "item": "https://questionsmedicales.fr/mesh/D010825" }, { "@type": "ListItem", "position": 4, "name": "Technologie des fibres optiques", "item": "https://questionsmedicales.fr/mesh/D005336" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Technologie des fibres optiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Technologie des fibres optiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Technologie des fibres optiques", "description": "Comment les fibres optiques sont-elles utilisées en imagerie médicale ?\nQuels tests utilisent la technologie des fibres optiques ?\nLes fibres optiques peuvent-elles détecter des cancers ?\nQuel rôle jouent les fibres optiques dans l'endoscopie ?\nPeut-on utiliser des fibres optiques pour surveiller des maladies chroniques ?", "url": "https://questionsmedicales.fr/mesh/D005336?mesh_terms=Case-Control+Studies&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Technologie des fibres optiques", "description": "Quels symptômes peuvent indiquer un problème avec les fibres optiques médicales ?\nLes patients ressentent-ils des douleurs lors de l'utilisation de fibres optiques ?\nQuels effets secondaires peuvent survenir après une procédure avec fibres optiques ?\nLes fibres optiques peuvent-elles causer des réactions allergiques ?\nQuels signes indiquent une infection après une procédure avec fibres optiques ?", "url": "https://questionsmedicales.fr/mesh/D005336?mesh_terms=Case-Control+Studies&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Technologie des fibres optiques", "description": "Comment prévenir les infections lors de l'utilisation de fibres optiques ?\nQuelles précautions prendre avant une procédure avec fibres optiques ?\nComment assurer la sécurité des dispositifs à fibres optiques ?\nLes patients doivent-ils être informés des risques des fibres optiques ?\nQuelles sont les meilleures pratiques pour l'utilisation des fibres optiques ?", "url": "https://questionsmedicales.fr/mesh/D005336?mesh_terms=Case-Control+Studies&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Technologie des fibres optiques", "description": "Comment les fibres optiques sont-elles utilisées en chirurgie ?\nLes fibres optiques sont-elles utilisées pour traiter des maladies oculaires ?\nQuel type de traitement utilise la technologie des fibres optiques en oncologie ?\nLes fibres optiques peuvent-elles être utilisées pour la physiothérapie ?\nComment les fibres optiques améliorent-elles les traitements de la douleur ?", "url": "https://questionsmedicales.fr/mesh/D005336?mesh_terms=Case-Control+Studies&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Technologie des fibres optiques", "description": "Quelles complications peuvent survenir après une procédure avec fibres optiques ?\nLes complications sont-elles fréquentes avec les fibres optiques ?\nComment gérer une infection après l'utilisation de fibres optiques ?\nLes complications peuvent-elles être évitées ?\nQuels signes indiquent une complication après une procédure ?", "url": "https://questionsmedicales.fr/mesh/D005336?mesh_terms=Case-Control+Studies&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Technologie des fibres optiques", "description": "Quels facteurs augmentent le risque de complications avec les fibres optiques ?\nLes antécédents médicaux influencent-ils les risques liés aux fibres optiques ?\nLe type de procédure influence-t-il les risques associés aux fibres optiques ?\nLes allergies aux matériaux affectent-elles l'utilisation des fibres optiques ?\nLe niveau d'expérience du praticien influence-t-il les risques ?", "url": "https://questionsmedicales.fr/mesh/D005336?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les fibres optiques sont-elles utilisées en imagerie médicale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent des procédures comme la fibroscopie pour visualiser l'intérieur du corps." } }, { "@type": "Question", "name": "Quels tests utilisent la technologie des fibres optiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la tomographie par cohérence optique (OCT) pour diagnostiquer des maladies." } }, { "@type": "Question", "name": "Les fibres optiques peuvent-elles détecter des cancers ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont utilisées pour des biopsies ciblées et des analyses de tissus." } }, { "@type": "Question", "name": "Quel rôle jouent les fibres optiques dans l'endoscopie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles éclairent et transmettent des images lors d'examens endoscopiques." } }, { "@type": "Question", "name": "Peut-on utiliser des fibres optiques pour surveiller des maladies chroniques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent un suivi en temps réel de certaines conditions médicales." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec les fibres optiques médicales ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des images floues ou des pertes de signal peuvent indiquer un dysfonctionnement." } }, { "@type": "Question", "name": "Les patients ressentent-ils des douleurs lors de l'utilisation de fibres optiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Généralement non, mais des sensations d'inconfort peuvent survenir selon la procédure." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent survenir après une procédure avec fibres optiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements légers ou des infections peuvent survenir après certaines interventions." } }, { "@type": "Question", "name": "Les fibres optiques peuvent-elles causer des réactions allergiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, mais des réactions peuvent survenir aux matériaux utilisés dans les dispositifs." } }, { "@type": "Question", "name": "Quels signes indiquent une infection après une procédure avec fibres optiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, gonflement ou écoulement au site d'insertion peuvent indiquer une infection." } }, { "@type": "Question", "name": "Comment prévenir les infections lors de l'utilisation de fibres optiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des dispositifs stériles et suivre des protocoles d'hygiène stricts." } }, { "@type": "Question", "name": "Quelles précautions prendre avant une procédure avec fibres optiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Informer le médecin des allergies et des médicaments en cours pour éviter des complications." } }, { "@type": "Question", "name": "Comment assurer la sécurité des dispositifs à fibres optiques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Effectuer des contrôles réguliers et des maintenances pour garantir leur bon fonctionnement." } }, { "@type": "Question", "name": "Les patients doivent-ils être informés des risques des fibres optiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une information claire sur les risques et bénéfices est essentielle avant toute procédure." } }, { "@type": "Question", "name": "Quelles sont les meilleures pratiques pour l'utilisation des fibres optiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Suivre les protocoles de formation et utiliser des équipements certifiés pour éviter les erreurs." } }, { "@type": "Question", "name": "Comment les fibres optiques sont-elles utilisées en chirurgie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent des interventions moins invasives grâce à la chirurgie laparoscopique." } }, { "@type": "Question", "name": "Les fibres optiques sont-elles utilisées pour traiter des maladies oculaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont utilisées dans des traitements comme la photocoagulation pour la rétine." } }, { "@type": "Question", "name": "Quel type de traitement utilise la technologie des fibres optiques en oncologie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie photodynamique utilise des fibres pour cibler et détruire les cellules cancéreuses." } }, { "@type": "Question", "name": "Les fibres optiques peuvent-elles être utilisées pour la physiothérapie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont utilisées dans des dispositifs de stimulation lumineuse pour la réhabilitation." } }, { "@type": "Question", "name": "Comment les fibres optiques améliorent-elles les traitements de la douleur ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées dans des dispositifs de laser pour soulager la douleur de manière ciblée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une procédure avec fibres optiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements, infections ou perforations peuvent survenir selon la procédure réalisée." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes avec les fibres optiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont rares, mais peuvent survenir, surtout si les protocoles ne sont pas respectés." } }, { "@type": "Question", "name": "Comment gérer une infection après l'utilisation de fibres optiques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement antibiotique peut être nécessaire, selon la gravité de l'infection." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en respectant les protocoles de sécurité et en formant correctement le personnel." } }, { "@type": "Question", "name": "Quels signes indiquent une complication après une procédure ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, douleur intense ou fièvre peuvent indiquer une complication post-procédure." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications avec les fibres optiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies chroniques et l'immunosuppression augmentent les risques." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils les risques liés aux fibres optiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de chirurgie ou d'infections peuvent augmenter les risques." } }, { "@type": "Question", "name": "Le type de procédure influence-t-il les risques associés aux fibres optiques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines procédures plus invasives comportent des risques plus élevés." } }, { "@type": "Question", "name": "Les allergies aux matériaux affectent-elles l'utilisation des fibres optiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des allergies peuvent entraîner des réactions indésirables lors de l'utilisation." } }, { "@type": "Question", "name": "Le niveau d'expérience du praticien influence-t-il les risques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un praticien expérimenté réduit le risque de complications lors des procédures." } } ] } ] }

Sources (10000 au total)

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev... A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus... Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);... The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...

Risk Factors for Postoperative Pneumonia: A Case-Control Study.

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ... A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch... Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent... Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ... www.chictr.org.cn, identifier: chiCTR2100045986....

Significance of temperature in antimuscarinic toxicity: a case-control study.

Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p... This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (... Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ... Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.

Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden... Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases... Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh... The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...

Anemia and Idiopathic Intracranial Hypertension: A Case-Control Study.

Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r... Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet... One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%... Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...

Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.

Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs.... Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor... Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant... Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...

Systemic hormone therapy and dementia: A nested case-control and co-twin control study.

The effect of systemic hormone therapy (HT) on dementia risk is unclear. Our aim was to investigate the association between HT and dementia.... This register-based study consists of a nested case-control study and a co-twin control design, which controls for familial confounding, including shared genetics.... Through Danish national registries from 1995 to 2011, we identified: a) 2700 female singletons with incident dementia and 13,492 matched controls; b) 288 female twins with incident dementia and co-twi... The odds ratio (OR) for the association between systemic HT and dementia was 1.05, 95% CI = [0.93-1.19] in singletons and 2.10, 95% CI = [0.99-4.46] in twins. A statistically significant association w... Using Danish nationwide registries and controlling for education and for familial factors in a subsample, systemic HT was found to be associated with increased dementia risk if used before 2003, when ...